Riverbridge Partners LLC Charles River Laboratories International, Inc. Transaction History
Riverbridge Partners LLC
- $7.1 Billion
- Q2 2024
A detailed history of Riverbridge Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Riverbridge Partners LLC holds 289,272 shares of CRL stock, worth $54.4 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
289,272
Previous 303,778
4.78%
Holding current value
$54.4 Million
Previous $82.3 Million
27.4%
% of portfolio
0.84%
Previous 1.04%
Shares
17 transactions
Others Institutions Holding CRL
# of Institutions
732Shares Held
51.8MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$956 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$393 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$359 Million0.99% of portfolio
-
Clearbridge Investments, LLC New York, NY1.37MShares$257 Million0.24% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...